CCN4 and neoplasm: A mutant analysis indicated that patients with urothelial carcinoma cells (UCC) carrying the rs2977530 genetic variants (AG + GG) have a higher risk of developing a more invasive tumor stage and larger tumor suggesting that WISP1 polymorphisms may serve as a marker or a therapeutic target in UCC [26].